US Patent 7902366 NK
Patent 7902366 was granted and assigned to Opko Health, Inc. on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+55 characters)
Article
Patent abstract
A NK1 antagonist having the formula (I),
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Anandan Palani0
Cheng Wang0
Dong Xiao0
Gregory A. Reichard0
Hon-Chung Tsui0
Juan D. Arredondo0
Michelle Laci Wrobleski0
Neng-Yang Shih0
Sunil Paliwal0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07902366 NK US Patent 7902366 NK
Infobox
Patent Number
07902366
Patent Number
7902366
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07902366 NK
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07902366
Date of patent
March 8, 2011
Patent application number
11358827
Date Filed
February 21, 2006
Patent primary examiner
Find more entities like US Patent 7902366 NK
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
